• Most Popular
  • Most Shared

EU agency supports new use of Merck's Gardasil

Mon Jun 2, 2008 7:00am EDT

Stocks

   

LONDON, June 2 (Reuters) - The European Medicines Agency has recommended that Merck & Co Inc's (MRK.N) cervical cancer vaccine Gardasil should also be approved for the prevention of high-grade vaginal dysplastic lesions.

Stocks  |  Regulatory News

Recommendations for marketing approval by the agency's Committee for Medicinal Products for Human Use (CHMP) are normally endorsed by the European Commission within a couple of months.

Gardasil is marketed in Europe via a 50:50 joint venture company with Sanofi-Aventis SA (SASY.PA). It competes with GlaxoSmithKline Plc's (GSK.L) rival product Cervarix. (Reporting by Ben Hirschler)

Stocks
Regulatory News


More from Reuters

Photo

Wide use of U.S. airport body scanners depends on Obama

NEW YORK (Reuters) - The path toward rolling out wider use of whole-body security scanners in U.S. airports runs through the White House.

» More Top News
EDITORS' NOTE: Reuters and other foreign media are subject to Iranian restrictions on leaving the office to report, film or take pictures in Tehran. A man holds a picture of Ayatollah Ruhollah Khomeini, founder of the Islamic Republic as government supporters protest against opposition demonstrations during the holy day of Ashura, in Tehran December, 30 2009. REUTERS/Caren Firouz

What next?

Six months after a disputed election, tension in Iran shows no signs of letting up.  Full Article 

IRAN
Disgraced financier Bernard Madoff is escorted by police and photographed by the media as he departs U.S. Federal Court after a hearing in New York, January 5, 2009. REUTERS/Lucas Jackson

I beg your pardon ...

Bernie Madoff became the poster boy of crooked investment schemes this year -- but he wasn't alone. Here's a look at the 10 most notorious cases of 2009.  Full Article 

Corporate Crime